Author: Hoff Communications
African American Advisory Board
MSAA’s African American Advisory Board is comprised of leading MS healthcare professionals, people living with MS, and care partners. The advisory board was established in 2019 to identify unmet needs […]
Read News Article
Best Practices in MS: What We Know, What We Don’t Know, and What We Hope
Featuring Barry Hendin, MD Expert neurologist and MSAA’s Chief Medical Officer Barry Hendin, MD provides an in-depth review of MS treatments and symptom management over the past few decades along […]
Read News ArticleWhat’s New in MS Research: September 2020
This edition of MSAA’s “What’s New in MS Research” article features highlights from the annual meetings of the American Academy of Neurology (AAN) and the Consortium of MS Centers (CMSC). Because of the ongoing COVID-19 pandemic, both of these meetings were held virtually. While not all of the reports are positive, the good far outweighs the rest, and encompasses not only promising research advances in MS, but also a potential role for a long-established DMT in treating COVID-19.
Read News Article
An Integrated Approach to Wellness for MS Patients and Care Partners
Featuring Mary R. Rensel, MD, ABIHM; Lucille Carriere, PhD; and Laura J. Kruskall, PhD, RDN, CSSD, LD, FACSM, FAND As the second program in the Health Promotion and Wellness in […]
Read News Article
Employment and Disability Benefits for People Living with MS
Featuring Jamie R. Hall, Esq. In this archived webcast, Social Security Disability claims attorney Jamie R. Hall, Esq. addresses many important employment issues affecting the MS community including disability disclosure, […]
Read News ArticleFDA Approves Kesimpta® (Ofatumumab), the First Self-Administered B-cell Therapy for Relapsing Forms of MS
Updated September 3, 2020 Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD On August 20, 2020, Novartis announced that the United States Food and Drug Administration (FDA) approved […]
Read News ArticleFDA Approves Generic Version of Tecfidera®, Taken Orally for MS
Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD On August 17, 2020, the United States Food and Drug Administration (FDA) awarded early approval of Mylan’s generic version of […]
Read News Article
Unlocking the Keys to Health and Wellness in MS
Featuring Carrie M. Hersh, DO, MSc and Shaina Meyer, OTR/L, MSCS Setting goals and establishing health-promoting behaviors, such as exercise and stress management, can be overly daunting. This 90-minute webinar […]
Read News Article
What You Need to Know About COVID-19 and MS – Program 6
Featuring Barry Hendin, MD and Carrie Hersh, DO, MSc Broadcasted on August 17, 2020, this sixth installment of our ongoing webinar series provides the latest news and updates at the […]
Read News Article